Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)
US11357777B2 · kind B2 · utility
0Cited by
0References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 31, 2017 |
| Grant date | Jun 14, 2022 |
| Priority date | — |
| Expiry date | Oct 16, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to methods, uses, pharmaceutical compositions and kits comprising an sGC stimulator or a pharmaceutically acceptable salt thereof, alone or in combination with one or more additional therapeutic agents, for the treatment of Nonalcoholic Steatohepatitis (NASH).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.